- Olsalazine
-
Olsalazine Systematic (IUPAC) name 5-[(2Z)-2-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazino]-2-hydroxybenzoic acid Clinical data Trade names Dipentum AHFS/Drugs.com monograph MedlinePlus a601088 Pregnancy cat. C(US) Legal status ℞-only (US) Pharmacokinetic data Protein binding 99% Half-life 0.9 hours Identifiers CAS number 15722-48-2 ATC code A07EC03 PubChem CID 6003770 DrugBank DB01250 ChemSpider 10642377 UNII ULS5I8J03O KEGG D00727 ChEMBL CHEMBL571540 Chemical data Formula C14H10N2O6 Mol. mass 302.239g/mol SMILES eMolecules & PubChem (what is this?) (verify) Olsalazine is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease such as Ulcerative Colitis. It is sold under the name Dipentum.
The chemical name is 3,3' -azobis (6-hydroxybenzoate)salicylic acid. It is sold as the disodium salt.
Like Balsalazide, Olsalazine is believed to deliver Mesalazine, or 5-aminosalicylic acid (5-ASA), past the small intestine, directly to the large intestine, which is the active site of disease in ulcerative colitis.
Contents
History
Olsalazine gained Food and Drug Administration (FDA) approval in 1990.
Supply
The drug is supplied by UCB Pharma.
Other indications
The Australian biotech company Giaconda has developed a combination therapy for treating constipation-predominant Irritable Bowel Syndrome that uses olsalazine and the anti-gout drug colchicine.
External links
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.